Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
491 studies found for:    lung tumor | Studies With Results
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
Conditions: Lung Cancer;   Small Cell Lung Cancer;   Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Ipilimumab;   Drug: Placebo;   Drug: Paclitaxel;   Drug: Carboplatin
2 Completed
Has Results
Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer
Condition: Lung Cancer
Intervention: Device: CyPath
3 Completed
Has Results
National Lung Screening Trial (NLST) Screening
Condition: Lung Cancer
Interventions: Device: low-dose helical computed tomography;   Device: chest radiography
4 Active, not recruiting
Has Results
Screening for Lung Cancer in Older Patients (PLCO Screening Trial)
Condition: Lung Cancer
Interventions: Procedure: radiography;   Other: screening questionnaire administration
5 Completed
Has Results
Phase I/II Calcitriol in Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Calcitriol
6 Completed
Has Results
A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: sunitinib
7 Terminated
Has Results
GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Pazopanib (GW786034)
8 Terminated
Has Results
Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer
Conditions: Malignant Pleural Effusion;   Non Small Cell Lung Cancer
Intervention: Drug: zoledronic acid
9 Completed
Has Results
Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer
Conditions: Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: carboxyamidotriazole;   Other: placebo;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
10 Completed
Has Results
Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Biological: Cetuximab;   Drug: Docetaxel
11 Completed
Has Results
A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
Conditions: Carcinoma;   Non Small Cell Lung
Interventions: Drug: Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®);   Drug: Placebo;   Drug: Docetaxel (Taxotere®);   Drug: Dexamethasone (pre- and post-medication for docetaxel)
12 Completed
Has Results
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Lung Cancer
Interventions: Drug: Docetaxel;   Drug: Vandetanib
13 Terminated
Has Results
A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Cancer;   Lung Cancer, Non-Small Cell
Intervention: Drug: GW572016 (lapatinib)
14 Active, not recruiting
Has Results
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: PF-02341066;   Drug: Pemetrexed;   Drug: Docetaxel
15 Active, not recruiting
Has Results
A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy
Condition: Non-Small Cell Lung Cancer
Interventions: Biological: Ramucirumab;   Drug: Placebo (for Ramucirumab);   Drug: Docetaxel
16 Completed
Has Results
Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
Conditions: Lung Cancer;   Precancerous Condition
Interventions: Drug: iloprost;   Other: placebo
17 Completed
Has Results
A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: erlotinib;   Drug: sunitinib;   Drug: placebo
18 Completed
Has Results
Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: topotecan hydrochloride
19 Active, not recruiting
Has Results
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
Condition: Non Squamous Lung Cancer
Intervention: Drug: treatment
20 Completed
Has Results
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Drug: RAD001 (everolimus)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years